ResMed’s new AirCurve11 series incorporates myAir and AirView digital health apps, which have increased patient compliance from 70% to 87% to provide maximum comfort and support during therapy.

ResMed tends to opt for strategic buyouts to boost SaaS revenues. As of the fiscal fourth-quarter end, the SaaS business reflected strong contributions from the MEDIFOX DAN brand in Germany and growth ...

New Patient Engagement Features for ResMed myAir App Designed to Help People Take Control of their Health ResMed myAir is an intuitive app that empowers patients to stay engaged with their CPAP ...

With a large installed base of more than 28 million patients in its AirView™ platform – and more than 8.3 million patients registered to the myAir™ platform – ResMed seamlessly integrates ...

It is seeking to funnel more patients towards its AirView and myAir platforms which integrate devices and data to enhance provider efficiency and enable more personalised care. ResMed chief financial ...

According to ResMed management, patient compliance increased from 70% to 87% as a result of using coaching features and having access to MyAir and AirView for tracking and seeing their nightly ...

The company’s two key global customer-facing software products — AirView and myAir — are 100% in the cloud. Currently, ResMed is investing in a portfolio of artificial intelligence-driven ...

ResMed makes it easier for people to manage their sleep health and stay on (continuous positive airway pressure) CPAP treatment by integrating its leading myAir™ consumer app with Apple and ...

ResMed makes it easier for people to manage their sleep health and stay on (continuous positive airway pressure) CPAP treatment by integrating its leading myAir™ consumer app with Apple and ...